• No results found

Downregulation and DNA methylation of ECRG4 in gastric cancer

N/A
N/A
Protected

Academic year: 2020

Share "Downregulation and DNA methylation of ECRG4 in gastric cancer"

Copied!
10
0
0

Loading.... (view fulltext now)

Full text

Loading

Figure

Figure 1 (Continued)
Figure 1 expression levels of ecrg4 in gastric cancer (gc). (A) heatmap of the 100 most downregulated genes in 45 gc patients, generated by analyzing the gse63089 data set; (B) ecrg4 mrna expression in 35 pairs of gc tissues and adjacent non-tumor tissues,
Table 1 ecrg4 protein levels and clinicopathological parameters of gc tissues
Figure 2 ECRG4-specific small interfering RNAs (siRNAs) promote the proliferation and invasion of gastric cancer (GC) cells
+3

References

Related documents

The analysis of the registry focused on detecting unwanted applications or unauthorized access to the machine with regard to the user activity via the VNC connection for the

The account balance changes can be used in an indirect method of Statement of Cash Flows to compute the forecasted dollar amount of operating cash flow for Yr.. Table 8: Use of

We have proposed a new mathematical epidemiological model with an isolated compartment and calculated its Basic reproduction number.. Also, we have discussed the equilibrium

Hence the present study was carried out to isolate fungal secondary metabolites from leaf of Pongamia pinnata and its antiviral activity against HSV-2 was

In this review we report a summary of the incidence of endophthalmitis following vitrectomy, various risk factors for their occurrence, the microbiological profile and the

with a history of missing ophthalmic examinations at our hospital or other ophthalmic clinics for more than a year (noncompliant group) and those without any previous

At zero temperature, the axial current, as a function of the angular velocity and chemical potential, vanishes in a two-dimensional plane region..

This study compared the safety and efficacy of dolutegravir 50 mg once daily versus raltegravir 400 mg twice daily in combination with an investigator-selected NRTI backbone in